A study conducted using electronic health record data from a collective of U.S. health care systems found that most adults ...
While medications such as methadone, buprenorphine, and naltrexone are FDA-approved for treating opioid use disorder, they ...
A 52-year-old man has knocked his decade-long cocaine addiction on the head after receiving weight-loss injections. The jab ...
Trulicity (dulaglutide) is a prescription drug that can cause weight loss in some people but is not approved for this use.
A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy ...
Peptide therapy enhances targeted medicine, utilizing specific peptides for effective treatment of cancer, metabolic disorders, and neurodegenerative diseases.
RAs, originally for diabetes, may impact brain health, finding potential benefits for dementia and addiction but inconsistent ...
Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...
A recent study from the University of Pennsylvania has confirmed that the injectable medication semaglutide can lead to major ...
Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...
Many patients with overweight or obesity discontinue glucagon-like peptide-1 (GLP-1) receptor agonist therapy within o ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results